Vanderbilt University Medical Center: Protein Study May Be Key to Treating Fibrotic Diseases
July 31, 2020
July 31, 2020
NASHVILLE, Tennessee, July 31 -- Vanderbilt University Medical Center issued the following news:
A protein linked to amyotrophic lateral sclerosis (ALS), a progressive neurological disease that causes muscle weakness, may be a key to treating fibrotic disease of the kidneys and other organs, researchers at Vanderbilt University Medical Center reported recently.
FUS is the acronym of a protein in the nucleus of cells that regulates DNA repair transcription, RNA splicing . . .
A protein linked to amyotrophic lateral sclerosis (ALS), a progressive neurological disease that causes muscle weakness, may be a key to treating fibrotic disease of the kidneys and other organs, researchers at Vanderbilt University Medical Center reported recently.
FUS is the acronym of a protein in the nucleus of cells that regulates DNA repair transcription, RNA splicing . . .